Michael Connor Jr., MD

Assistant Professor of Medicine

Department of Medicine

Office: Davis Fischer Bldg 3312

Phone: 404-686-8866

Fax: 404-686-2361

Email: michael.connor@emory.edu

Additional Contact Information

Additional Websites


Born and raised in Atlanta, Dr. Connor completed his Bachelor’s degree at the University of Notre Dame, and returned to Georgia to attend medical school at the Medical College of Georgia graduating in 2003.  He completed dual training in combined Internal Medicine & Pediatrics at Brown University in Providence, Rhode Island in 2007 where he became interested in both critical care medicine and nephrology with a particular interest in acute care nephrology in the adult intensive care units.  Dr. Connor underwent fellowship training in adult nephrology and critical care medicine at the Cleveland Clinic in Cleveland, Ohio between 2007-2010.  He joined the faculty of Emory University School of Medicine in September 2010 where he holds the rank of assistant professor.

Dr. Connor’s clinical and academic interests are focused heavily on critical care medicine and especially acute nephrology issues in the critically ill.  Dr. Connor is an internationally recognized expert on acute renal replacement therapies, acute kidney injury (AKI), antimicrobial dosing in AKI, volume management and hemodynamic support of the critically ill, intra-abdominal hypertension & abdominal compartment syndrome, acute acid/base derangements, and extracorporeal blood purification techniques including extra-corporeal membrane oxygenation.

In September 2014, Dr. Connor spearheaded the first-ever application of advanced critical care support to a patient with Ebola virus disease (EVD) which included the first known successful application of acute continuous hemodialysis and mechanical ventilatory support in EVD.


Connor MJ Jr, Kraft C, Mehta AK, Varkey JB, Franch HA, et al.  “Successful delivery of [Renal Replacement Therapy] RRT in Ebola virus disease.”  J Am Soc Nephrol. 2015;26(1):31-7.  PMID:  25398785.

Faubel S, Franch H, Vijayan A, Barron MA, Heung M, Liu KD, Koyner JL, Connor MJ Jr.  “Preparing for renal replacement therapy in patients with the ebola virus disease.”  Blood Purif. 2014;38(3-4):276-85.  PMID:  25675963.

Mazzeffi M, Paciullo C, Vega JD, Nguyen D, Connor MJ Jr.  “Rapid Increase in Perioperative Serum Sodium Concentration is Associated with an Increased Risk for Adverse Neurologic Events After Continuous Flow Left Ventricular Assist Device Implantation.”  J Cardiothorac Vasc Anesth. 2014 Dec 11.  [Epub ahead of print].  PMID:  25499669.

Razavi SAStill MDWhite SJ, Buchman TG, Connor MJ Jr.  “Comparison of Circuit Patency and Exchange Rates Between Two Different Continuous Renal Replacement Therapy Machines.”  Journal of Critical Care.  2014;29(2):272-7.  PMID:  24360820.

Afshartous D, Bauer SR, Connor MJ Jr, Aduroja OA, Amde M, Salem C, Groszek JJ, Fissell WH. “Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis.”Am J Kidney Disease.  2014;63(1):170-1.  PMID: 24145021

Paciullo CAHarned KCDavis GAConnor MJ JrWinstead PS.  “Vancomycin clearance in high-volume venovenous hemofiltration.”  Annals of Pharmacotherapy.  2013;47(3):e14. PMID: 23404801

Bauer SR, Salem C, Connor MJ Jr, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH.  “Pharmacokinetics and Pharmacodynamics of Piperacillin-Tazobactam in 42 Patients Treated with Concomitant CRRT.”  CJASN.  2012;7(3):452-7.  PMID #:  22282479

Connor MJ Jr, Salem C, Bauer S, Fissel W, et al.  “Therapeutic Drug Monitoring of Piperacillin-Tazobactam Using Spent Dialysate Effluent in Patients Receiving Continuous Venovenous Hemodialysis.”  Antimicrobial Agents & Chemother.  Feb 2011;55(2):557-60.  PMID #:  21115798